Protecting the female germ line from cancer therapy

Nature Medicine

Volumn 6, Issue 10, 2000, Pages 1100-1101

  Casper, R F ^a   Jurisicova, A ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE 1 PHOSPHATE;

APOPTOSIS; BONE MARROW TRANSPLANTATION; CANCER THERAPY; CELL DEATH; FEMALE; FEMALE STERILITY; HUMAN; HUMAN CELL; LEUKEMIA; LYMPHOMA; MENOPAUSE; OOCYTE; OVARY DISEASE; PRIORITY JOURNAL; SHORT SURVEY;

ANIMAL; APOPTOSIS; FEMALE; HUMAN; MICE; NEOPLASMS; OOCYTES; PROTO-ONCOGENE PROTEINS; RADIATION-PROTECTIVE AGENTS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

EID: 0033782743     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/80427     Document Type: Short Survey

References (10)

1. Docyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy
2. Sphingosine-1-phosphate: Signaling inside and out
3. Apoptosis-associated signalling pathways are required for chemotherapy-mediated female germ cell destruction
4. Lysophosphatidic acid and sphingosine 1-phosphate protection of T cells from apoptosis in assoociation with suppression of bax
5. Patterns of gonadal dysfunction following bone marrow transplantation
6. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation in childhood
7. Pharmacological protection of the gonads. A review
8. A review of the epidemiology of human breast cancer
9. Early age at menopause and breast cancer: Are leaner women more protected? A prospective analysis of the Dutch DOM cohort
10. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin